SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-016511
Filing Date
2015-03-17
Accepted
2015-03-16 20:47:06
Documents
7
Period of Report
2015-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v404684_8k.htm 8-K 24634
2 EXHIBIT 10.1 v404684_ex10-1.htm EX-10.1 207844
3 EXHIBIT 10.2 v404684_ex10-2.htm EX-10.2 83205
4 EXHIBIT 10.3 v404684_ex10-3.htm EX-10.3 218324
5 EXHIBIT 10.4 v404684_ex10-4.htm EX-10.4 222707
6 EXHIBIT 10.5 v404684_ex10-5.htm EX-10.5 12650
7 EXHIBIT 10.6 v404684_ex10-6.htm EX-10.6 15049
  Complete submission text file 0001144204-15-016511.txt   785999
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-17263 | Film No.: 15704667
SIC: 2836 Biological Products, (No Diagnostic Substances)